Basic and Diluted Net Loss per Share |
Basic and Diluted Net Loss per Share The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three months ended April 30, 2023 and 2022: | | | | | | | | | | | | | | | | | Three Months Ended April 30, | | | | 2023 | | 2022 | | | | | | (in thousands, except share and per share data) | Numerator: | | | | | | | | Net loss | $ | (79,388) | | | $ | (89,266) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Denominator: | | | | | | | | Weighted average common shares outstanding | 350,073,545 | | | 334,743,634 | | | | | | Less: Weighted average unvested restricted shares and shares subject to repurchase | (30,091) | | | (119,939) | | | | | | Weighted average shares outstanding - Basic and Diluted | 350,043,454 | | | 334,623,695 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net loss per share - Basic and Diluted | $ | (0.23) | | | $ | (0.27) | | | | | | | | | | | | | |
The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows: | | | | | | | | | | | | | | | April 30, 2023 | | April 30, 2022 | | | 2027 Convertible Notes (on an as-converted basis) | 12,483,569 | | | 12,483,569 | | | | Options to purchase common stock | 16,218,804 | | | 20,781,407 | | | | Restricted stock units | 11,948,903 | | | 4,370,671 | | | | Unvested early exercised common stock options | 22,636 | | | 109,185 | | | | Common stock warrants | 34,499,436 | | | 35,524,021 | | | | Employee stock purchase plan | 2,975,905 | | | 2,546,487 | | | | Total potentially dilutive common share equivalents | 78,149,253 | | | 75,815,340 | | | |
PRSUs granted were excluded from the above table because the respective stock price targets have not been met as of April 30, 2023.
|